Close
Nordic 9Nordic 9

Inven2 (investor - Corporate Investor)

Norway inven2.com
See something wrong or missing? Let us know
Offices:Oslo

Inven2 is the next-generation innovation company, established to maintain and develop Norwegian innovations by building bridges between excellent research and the next generation technology based industry.

Inven2 is the largest contributor in Norway within the field of commercialization of research, owned by the University of Oslo and Oslo University Hospital, Norway's largest and leading university and hospital representing pioneering research.

Average round investment:7.56M USD
Average number per year:1.2
Distribution: 2025 (1)2020 (1)2017 (1)2016 (1)2012 (2) See the entire list
Portfolio companies: Sweden Tribune TherapeuticsNorway Zelluna Immunotherapy AsNorway AIMS Innovation See the entire list
Mostly invests in: Norway Norway (6) Health services (4)
See the entire list

Showing 3 of 7 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Inven2

Name Criteria
Poland Alfabeat
92%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Security, Software Services, Manufacturing
  • Similar business models: B2B, SAAS
  • Common investees countries: Sweden
  • Average number of deals per year: 1.2
  • Active last 12 months: Yes
Switzerland Swisshealth Ventures
92%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Health services, Software Services, Manufacturing
  • Similar business models: B2B, SAAS
  • Common investees countries: Sweden
  • Average number of deals per year: 1.2
  • Active last 12 months: Yes
Netherlands Fashion For Good
92%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Software Services, Biotech, Manufacturing
  • Similar business models: B2B, SAAS
  • Common investees countries: Sweden
  • Average number of deals per year: 1.2
  • Active last 12 months: Yes
Norway Alden
92%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Health services, Software Services, Manufacturing, Hardware
  • Similar business models: B2B, SAAS
  • Common investees countries: Norway
  • Average number of deals per year: 1.2
  • Active last 12 months: Yes
Norway Bonheur
92%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Software Services, Manufacturing, Hardware
  • Similar business models: B2B, SAAS
  • Common investees countries: Norway
  • Average number of deals per year: 1.2
  • Active last 12 months: Yes
United Kingdom Centrica
92%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Security, Software Services, Manufacturing, Hardware
  • Similar business models: B2B, SAAS
  • Common investees countries: Sweden
  • Average number of deals per year: 1.2
  • Active last 12 months: Yes
Denmark Thomas Madsen-Mygdal
92%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Health services, Security, Software Services, Manufacturing
  • Similar business models: B2B, SAAS
  • Common investees countries: Sweden
  • Average number of deals per year: 1.2
  • Active last 12 months: Yes
United Kingdom Josh Buckley
92%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Software Services, Biotech, Pharma, Manufacturing, Hardware
  • Similar business models: B2B, SAAS
  • Common investees countries: Norway
  • Average number of deals per year: 1.2
  • Active last 12 months: Yes
Hong Kong ADM Capital
92%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Health services, Software Services, Manufacturing
  • Similar business models: B2B, SAAS
  • Common investees countries: Norway
  • Average number of deals per year: 1.3
  • Active last 12 months: Yes
Norway Kvantia
92%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Health services, Software Services, Biotech, Manufacturing
  • Similar business models: B2B, SAAS
  • Common investees countries: Norway
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Top